Black Fungus in India: Govt Allocates Additional 1.7 Lakh Vials of Mucormycosis Drug Amphotericin-B to States, UTs, Says Union Minister Sadananda Gowda
Gowda added that an additional 15,520 vials of the critical drug have been allocated to Karnataka. "So far, a total of 40,470 vials of the drug have been allocated to the state including today's allocation for timely treatment of patients," he said.
New Delhi, June 9: The government has allocated an additional 1.7 lakh vials of Amphotericin-B drug, used to treat black fungus infection, to states and union territories, Union Minister Sadananda Gowda said on Wednesday.
"Ensuring adequate availability and smooth supply of #Amphotericin-B across the country, additional 1,70,000 vials of the drug have been allocated to all the States/UTs & Central Institutions today," the chemicals and fertilisers minister tweeted.
Gowda added that an additional 15,520 vials of the critical drug have been allocated to Karnataka. "So far, a total of 40,470 vials of the drug have been allocated to the state including today's allocation for timely treatment of patients," he said. Mucormycosis in India: What Makes People Prone to Black Fungus? Know How the Fungal Infection Is Linked With Diabetes, Post COVID-19 Treatment and More.
Amphotericin-B is used to treat Mucormycosis, also known as black fungus, which damages the nose, eyes, sinuses, and sometimes even the brain.
Mucormycosis can be life-threatening in diabetic or severely immuno-compromised individuals such as cancer patients or people with HIV/AIDS.
The doctors in India are documenting an alarming number of cases of Mucormycosis among patients with COVID-19 and those who have recently recovered. They believe that Mucormycosis may be triggered by the use of steroids, a life-saving treatment for severe and critically ill COVID-19 patients.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)